105 related articles for article (PubMed ID: 19715949)
1. Causes and predisposing factors of de novo tumors in our series of liver transplant recipients.
Tallón Aguilar L; Barrera Pulido L; Bernal Bellido C; Pareja Ciuró F; Suárez Artacho G; Alamo Martínez JM; García González I; Gómez Bravo MA; Bernardos Rodríguez A
Transplant Proc; 2009; 41(6):2453-4. PubMed ID: 19715949
[TBL] [Abstract][Full Text] [Related]
2. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
3. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
4. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
5. De novo tumors after liver transplantation: a single-institution experience.
Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for development of de novo neoplasia after liver transplantation.
Xiol X; Guardiola J; Menendez S; Lama C; Figueras J; Marcoval J; Serrano T; Botargues JM; Mañer M; Rota R
Liver Transpl; 2001 Nov; 7(11):971-5. PubMed ID: 11699033
[TBL] [Abstract][Full Text] [Related]
7. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
[TBL] [Abstract][Full Text] [Related]
8. Cancers of new appearance in liver transplant recipients: incidence and evolution.
Romero-Vargas ME; Flores-Cortés M; Valera Z; Gómez-Bravo MA; Barrera-Pulido L; Pareja-Ciuró F; Serrano Díez-Canedo J; García I; Bernardos A
Transplant Proc; 2006 Oct; 38(8):2508-10. PubMed ID: 17097983
[TBL] [Abstract][Full Text] [Related]
9. De novo posttransplantation nonlymphoproliferative malignancies in liver transplant recipients.
Boin I; Leonardi MI; Stucchi RB; Ataide EC; Almeida JR; Barros RH; Leonardi LS
Transplant Proc; 2007 Dec; 39(10):3284-6. PubMed ID: 18089372
[TBL] [Abstract][Full Text] [Related]
10. Low recurrence of preexisting extrahepatic malignancies after liver transplantation.
Benten D; Sterneck M; Panse J; Rogiers X; Lohse AW
Liver Transpl; 2008 Jun; 14(6):789-98. PubMed ID: 18412260
[TBL] [Abstract][Full Text] [Related]
11. [Incidence of de novo neoplasms after liver transplantation].
Berenguer M; Prieto M; Bustamante M; Carrasco D; López-Andújar R; Mir J; Berenguer J
Med Clin (Barc); 1998 Oct; 111(13):481-4. PubMed ID: 9859063
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
[TBL] [Abstract][Full Text] [Related]
13. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
14. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection of pulmonary malignant tumors after living donor liver transplantation.
Shoji F; Kawano D; Ikegami T; Soejima Y; Taketomi A; Yano T; Maehara Y
Ann Thorac Surg; 2009 Jul; 88(1):206-11. PubMed ID: 19559227
[TBL] [Abstract][Full Text] [Related]
16. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases.
Jiménez-Romero C; Manrique Municio A; Marqués Medina E; Colina F; Ortega Domene P; Gómez Sanz R; Meneu Diaz JC; Abradelo de Usera M; Moreno Elola A; Moreno Gonzalez E
Transplant Proc; 2006 Oct; 38(8):2505-7. PubMed ID: 17097982
[TBL] [Abstract][Full Text] [Related]
17. De novo malignancies after kidney transplantation.
Hung YM; Chou KJ; Hung SY; Chung HM; Chang JC
Urology; 2007 Jun; 69(6):1041-4. PubMed ID: 17572182
[TBL] [Abstract][Full Text] [Related]
18. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
Buell JF; Papaconstantinou HT; Skalow B; Hanaway MJ; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):960-1. PubMed ID: 15848590
[TBL] [Abstract][Full Text] [Related]
19. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
